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Point mutations to the human gene TPM1 have been implicated in the development of
both hypertrophic and dilated cardiomyopathies. Such observations have led to studies
investigating the link between single residue changes and the biophysical behavior of
the tropomyosin molecule. However, the degree to which these molecular perturbations
explain the performance of intact sarcomeres containing mutant tropomyosin remains
uncertain. Here, we present a modeling approach that integrates various aspects
of tropomyosin’s molecular properties into a cohesive paradigm representing their
impact on muscle function. In particular, we considered the effects of tropomyosin
mutations on (1) persistence length, (2) equilibrium between thin filament blocked and
closed regulatory states, and (3) the crossbridge duty cycle. After demonstrating the
ability of the new model to capture Ca-dependent myofilament responses during both
dynamic and steady-state activation, we used it to capture the effects of hypertrophic
cardiomyopathy (HCM) related E180G and D175N mutations on skinned myofiber
mechanics. Our analysis indicates that the fiber-level effects of the two mutations can be
accurately described by a combination of changes to the three tropomyosin properties
represented in the model. Subsequently, we used the model to predict mutation effects
on muscle twitch. Both mutations led to increased twitch contractility as a consequence
of diminished cooperative inhibition between thin filament regulatory units. Overall,
simulations suggest that a common twitch phenotype for HCM-linked tropomyosin
mutations includes both increased contractility and elevated diastolic tension.
Keywords: tropomyosin, tropomyosin-actin interactions, tropomyosin stiffness, cooperativity, hypertrophic
cardiomyopathy, computational modeling, diastolic dysfunction
INTRODUCTION
Point mutations in alpha tropomyosin (TPM1) are associated with inherited cardiomyopathies,
most notably hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM)
(Redwood and Robinson, 2013).While there is no consistent pattern predicting whether amino acid
substitutions will lead to HCM versus DCM, mutations are known to alter the interactions within
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the tropomyosin coiled-coil itself and between tropomyosin and
its binding partner actin (Bai et al., 2013; Redwood and Robinson,
2013). Studies on the classic HCM-related tropomyosin mutants
E180G and D175N (Thierfelder et al., 1994) using electron
microscopy, atomic force microscopy, and molecular dynamics
on isolated tropomyosin have shown increased local and global
flexibility (Li et al., 2010, 2012; Loong et al., 2012b). Changes in
tropomyosin flexibility are widely believed to affect thin filament
cooperativity (Loong et al., 2012a; Moore et al., 2016). However,
recent work has shown that point mutations in tropomyosin
can also affect the energy landscape of tropomyosin interactions
with actin, providing another potential route for mutations
to affect thin filament calcium regulation (Orzechowski et al.,
2014a,b). Altered actin binding by mutant tropomyosin is also
supported by numerous experimental and computational studies
(Boussouf et al., 2007; Janco et al., 2012; Zheng et al., 2016).
The surface interactions of tropomyosin and actinmay ultimately
affect myosin crossbridge formation, as suggested by length
perturbation analysis studies (Bai et al., 2011). Based on these
observations, we posit that emergent physiological effects of
tropomyosin mutations can be described by considering the
effects of residue changes on both the chain-like properties
of the tropomyosin molecule and interaction of tropomyosin
with the actin surface as it fluctuates between regulatory
states.
In order to construct a paradigm for exploring the effects
of tropomyosin properties on muscle activation, we employed
a computational approach. Beginning with a previous model
of thin filament calcium activation (Aboelkassem et al., 2015),
we reconsidered the formulation of tropomyosin neighbor
interactions, bringing it into closer agreement with structural
measurements of tropomyosin movement on actin. The
completed model includes parameters that unambiguously relate
to three potential mutation-dependent molecular properties
of tropomyosin, namely tropomyosin chain stiffness, blocked-
closed equilibrium, and the crossbridge duty cycle. Making
use of published data, we found that the model was capable of
capturing steady-state behavior of cardiac muscle preparations
containing wild-type and mutant tropomyosins. Furthermore,
the simulations suggest that HCM-related tropomyosin
mutations produce hypercontractile twitch phenotypes with
diastolic dysfunction.
METHODS
Model Formulation
Consider an actin regulatory unit (RU) having a current
state Z ∈ {B, C,M} after the three state model established
by McKillop and Geeves (1993) (Figures 1A,B). In order to
transition to a different state, Z∗, the RU must overcome an
activation energy which we denote1G
ref
ZZ∗ .
Because direct transitions between B andM are prohibited
(Figure 1A), this yields a total of four reference activation
energies, 1G
ref
BC, 1G
ref
CB, 1G
ref
CM, and 1G
ref
MC (Figure 1D). These
energies correspond to theoretical reference conditions in which
the RU is not connected to its nearest neighbors. From these, it
is possible to construct a baseline free energy landscape for RU
transitions (depicted conceptually as the gray line in Figure 1D).
Having established a reference free energy landscape, the
effects of nearest neighbors can be evaluated. Consider a
thin filament formed of discrete RUs connected in series
(Campbell et al., 2010). Each RU has structural links with its
neighbors through tropomyosin-tropomyosin overlap along the
thin filament (McLachlan and Stewart, 1975). We include the
effect of Tm-Tm overlap by determining the potential energy
stored in the entire Tm chain itself when adjacent RUs do not
occupy the same state (Figures 1B,E). The potential energy is
assumed to arise from distortion of the Tm chain according
to the difference in azimuthal angle between adjacent Tm. In
preliminary calculations, we determined the energy stored in
an elastically jointed chain cantilevered at one end and loaded
(orthogonal to the un-deformed chain) at the other (Figure 1B).
We found that the total chain energy was proportional to the
square of the azimuthal angle change subtended by the bending
chain. In terms of stored energy, this result is equivalent to a
virtual spring element connecting RUs azimuthally. Accordingly,
rather than represent a continuous chain in the model, we
adopted a mechanical analog in which each Tm was considered
attached to its neighbors via a linear elastic element (Figure 1C).
When adjacent RUs occupy the same state, the distortion in
their linking spring and its developed elastic force is zero.
When they occupy different states, the force is proportional to
the azimuthal angle (φ) that separates them. The constant of
proportionality is the effective Tm chain stiffness γ . Hence, the
potential energy contributed to an RU by its left neighbor (having
state X ∈ {B,C,M}) is:
1UXZ =
1
2
γ(φZ − φX)
2 (1)
The same equation applies analogously to the right neighbor,
having state Y ∈ {B,C,M}:
1UYZ =
1
2
γ(φZ − φY )
2 (2)
The azimuthal angles of tropomyosin for each state are taken
from structural data (Vibert et al., 1997; Poole et al., 2006),
namely φB = 0
◦, φC = 25
◦, and φM = 35
◦. We further assume
that the peak free energy barrier between states coincides with an
azimuthal angle precisely halfway between the angles associated
with each state, that is:
φBC = φCB =
1
2
(φC − φB)+ φB
and
φCM = φMC =
1
2
(φM − φC)+ φC
The potential energy due to Tm chain distortion at these
intermediate angles, accounting for the left-neighbor state X is:
△UX
ZZ
∗ =
1
2
γ(φZZ∗ − φX)
2, (3)
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FIGURE 1 | Schematic diagram of model components, states, and conceptual underpinning of the cooperativity scheme. (A) State diagram for the
assumed six states in the thin filament model with kinetic rates governing each state transition (shaded). (B) The model takes into account the azimuthal angle
displacement required for the state transition from blocked to closed to open for a given regulatory unit. Quasi-explicit representation of Tm bending shows that stored
energy in the molecule is proportional to the square of the azimuthal angle change. (C) This suggests that the system can be represented simply as a given regulatory
unit Z connected to its neighbors X and Y by linear springs. (D) The conceptual reaction coordinate diagram for a given regulatory unit detached from its neighbors
considers the free energy barrier from the blocked state to closed state to open state. (E) Magnitude of strain energy contribution for a given neighbor X depends on
the intermediate angles between a transition for the state of a given regulatory unit and the state of the neighbor. (F) The overall energy barriers for the transitions of a
given regulatory unit depends on the contribution of the strain energy with respect to the states of its neighbors X and Y.
where Z is the current state of the RU, and Z∗ is the state into
which the RU is transitioning. Similarly, the potential energy
contribution of the right neighbor (having state Y) is
△UY
ZZ
∗ =
1
2
γ(φZZ∗ − φY )
2 (4)
The final activation energy for any given transition ZZ∗ with
neighboring RU states X and Y is obtained by altering the
reference activation energy as follows:
1GXY
ZZ
∗ = 1G
ref
ZZ
∗ −1U
X
Z +1U
X
ZZ
∗ −1UYZ +1U
Y
ZZ
∗ (5)
In other words, distortion-based increases in potential energy
raise energy wells, hence the two negative terms in the above
equation that diminish the reference activation energy. On the
other hand, distortion increases the height of the peaks in
between states, adding to the activation energy. This explains the
positive potential energy terms.
Once activation energies are defined, neighbor-dependent
kinetic rates can be obtained via the Eyring equation:
kXY
ZZ
∗ =
kbT
h
e
−1GXY
ZZ
∗ /RT (6)
For convenience, we define a reference kinetic rate based on the
reference energy change1G
ref
ZZ∗ :
k
ref
ZZ∗ =
kbT
h
e−1G
ref
ZZ∗
/RT
Using Equation (5), k
ref
ZZ∗ can be substituted into Equation (6):
kXYZZ∗ = k
ref
ZZ∗e
(
−1UXZ + 1U
X
ZZ∗
−1UYZ + 1U
Y
ZZ∗
)
(7)
Equation (7) casts tropomyosin transition rates as a reference
kinetic rate scaled by a term that reflects that status of nearest
neighbors as well as the apparent tropomyosin chain stiffness
(Equations 1–4). In order to conform to nomenclature of
previous models, C→M and M→C transition rates are referred
to as f and, g as these transitions are driven by crossbridge
binding and unbinding, respectively:
f XY = k
XY
CM
gXY = k
XY
MC
In addition to tracking the tropomyosin state of each RU, we also
represent Ca2+ binding to TnC. As introduced in Aboelkassem
et al. (2015) we permit all three tropomyosin RU states to be
either Ca2+ bound or Ca2+ free (denoted by subscripts 1 or 0,
respectively). This produces a six-state RU model (Figure 1A).
In order to reflect the fact that transition away from the B state
seldom occurs without Ca2+ first binding to TnC, the kinetic
rate kXYBC is scaled by the factor λ for the transition B0→C0. The
Ca2+ dissociation rate kdCa is also scaled by λ for C1→C0 and
M1→M0 transitions in order to satisfy microscopic reversibility
(Aboelkassem et al., 2015). Ca2+ association with the RU is
governed by the second order rate constant kCa+.
Frontiers in Physiology | www.frontiersin.org 3 October 2016 | Volume 7 | Article 473
Sewanan et al. Predicting Effects of Tropomyosin Mutations
Model Implementation
A total of 24 RUs, each obeying the six-state scheme described
above, were connected in series to form a virtual thin filament.
Dummy RUs, one on each end of the filament, were added
and permanently fixed in the B0 position to define boundary
conditions. Simulations were performed on the system using
a Markov chain Monte Carlo algorithm described previously
(Aboelkassem et al., 2015). Force produced by the model was also
computed as before by averaging the output of many repeated
simulations. The time step size for simulations was automatically
determined for each parameter set such that the maximum
cumulative probability of transition for any combination of
nearest neighbor states never exceeded 0.7. To guarantee the
accuracy of this heuristic threshold, simulations were tested
for convergence at other time step values. The 0.7 transition
threshold proved more than sufficient to guarantee temporal
convergence in each case.
Simulation protocols included both activations at a
single, constant Ca2+ concentration and under time-varying
intracellular Ca2+ concentration (for twitch). Data for fitting
steady-state and twitch activation (Janssen and de Tombe, 1997;
Dobesh et al., 2002; Bai et al., 2011) were digitized using a custom
script that loaded a bitmap of each figure into MATLAB and
located the pixel corresponding to the centroid of each data
markers. Digitized data points were then overlaid on the original
images to check for fidelity. RUs were always set to an initial state
of B0 at the beginning of each simulation. In order to obtain
steady-state force and rates of tension recovery (ktr), the model
was run for a 7500ms interval (achieving steady force) and
then all RUs inM states were instantaneously transitioned into
C states. The rate at which force recovered to the steady-state
value was used to determine ktr (Figure 2A). The model was
implemented in CUDA C++ and executed on an Nvidia Tesla
K40 graphic processing card. Custom MATLAB scripts were
created to manage simulation setup and data flow.
RESULTS
Implementation of the new formulation (Figure 1) of
tropomyosin nearest neighbor interaction constrained by
biophysical measurements on tropomyosin azimuthal change
(Poole et al., 2006) decreases the number of free parameters
of the model by four. This constitutes a drastic reduction in
potentially adjustable parameters and in model dimensionality
compared to the previous formulation (Aboelkassem et al.,
2015). To determine whether the model could still lead
to behavior consistent with realistic calcium activation of
muscle, we used constrained particle swarm optimization
to find a set of parameters (Table 1, Set 1) that accurately
matched calcium-dependent steady-state force production
reported in skinned rat trabeculae (Figure 2; Dobesh et al.,
2002). The dataset of Dobesh et al. (obtained at a sarcomere
length of 2.25µm) was selected because of the meticulous
attention paid to sarcomere length stability in that study.
The simulation reproduced not only the steady state force-
pCa relationship as reported (Figure 2B) with roughly the
same Hill coefficient and pCa50 over the experimental pCa
range (Table 2) but also showed a strong dependence of the
rate of force redevelopment on pCa (Figure 2A), consistent
with experimental observation (Fitzsimons et al., 2001). The
simulation furthermore manifested asymmetry in the lower
half of the force-pCa relationship compared to the upper half
such that a higher Hill coefficient can be calculated at the lower
half than the upper half (Figure 2B). While an asymmetric
cooperativity leads to deviation of the simulation curve from an
idealized Hill curve with the same apparent cooperativity, real
muscle including the skinned trabeculae modeled here defies
uniform cooperativity in its force-pCa relationship (Dobesh
et al., 2002).
Having obtained a parameter set for skinned cardiac muscle,
we perturbed each of the model parameters that could potentially
be affected by tropomyosin mutations (Li et al., 2012; Bai
et al., 2013; Orzechowski et al., 2014a) in order to understand
their separate effects on the steady state force-pCa relationship
(Figure 3). The same relative changes in tropomyosin stiffness
γ , BC equilibrium constant KBC, and myosin duty cycle δ were
used to generate force-pCa curves (Figures 3A–C) with their
properties quantified as maximum force, fraction of maximum
force present at diastolic (low) calcium, calcium sensitivity, and
Hill coefficient. The three troponin-related parameters (λ, kCa+,
kCa−) were not perturbed in this analysis. The forward rates
of BC transition and of myosin binding were also excluded
A B
FIGURE 2 | Fitting of skinned rat trabeculae steady state force-pCa data. (A) The model showed realistic calcium dependence of steady-state force and the
rate of force development (ktr) after a slack-restretch maneuver. (B) The model was able to fit steady-state force-pCa data and recapitulate the asymmetric Hill
coefficient observed in experiments (data from Dobesh et al., 2002).
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TABLE 1 | Parameters used for fitting data and running simulations.
Parameter Set 1 Set 2 Set 2 Set 2 Set 3 Set 4 Set 5
Skinned filament Reconstituted w E180G
changes
w D175N
changes
Intact rat trabeculae Intact rat
trabeculae
Intact Rat
Trabeculae(Dobesh et al., 2002) myocardium (Janssen and de
Tombe, 1997)(Bai et al., 2011) w E180G
changes
w D175N
changes
kCa− (ms
−1) 0.58 0.471 6.0
kCa+(uM
−1ms−1) 0.125 0.1003 6.0
KBC 0.898 7.0
kref
BC
(ms−1) 1.83 1.9524 2.1476 1.6595 1.2963 1.4259 1.212
γ (mol−1kJ) 68.00 37.64 28.20 22.60 68.00 51.00 40.80
f ref (ms−1) 0.0058 0.132
δ 0.4754 0.4951 0.5694 0.4951 0.715 0.822 0.715
λ 0 0.20 0.06
TABLE 2 | Tropomyosin wild-type fit simulation and data properties.
Parameter Experimental
average data
(Bai et al., 2011)
Simulated
curve
Experimental
average data
(Dobesh et al., 2002)
Simulated
curve
nH 1.78 1.91 6.9 6.7
pCa50 6.0 6.0 5.5 5.5
because the absolute rates have little effect on the steady state
force-pCa curves (data not shown). The maximum steady state
force production was strongly dependent on the myosin duty
cycle whereas tropomyosin stiffness and BC equilibrium had only
small effects on the maximum force (Figure 3D). Examining the
effect closely of stiffness and BC equilibrium revealed that they
had primarily fine tuning but opposing effects on maximum
force production, with higher stiffness slightly decreasing force
production and higher BC equilibrium slightly increasing force
production. The force present at low calcium (Figure 3E) was
most sensitive to tropomyosin stiffness. Decreasing the stiffness
parameter causes a drastic, non-linear increase in force at low
calcium. Proportional increases in BC equilibrium and duty
cycle increased force at low calcium, but these changes were
modest by comparison (Figure 3E). While increases in BC
equilibrium constant and duty cycle tended to increase the
calcium sensitivity of the thin filament in these simulations
(Figure 3F), increased stiffness had the opposite effect. BC
equilibrium had a larger effect on calcium sensitivity than duty
cycle. Cooperativity (as assessed by the Hill coefficient) was
affected by all three parameters, but more particularly myosin
duty cycle and tropomyosin stiffness (Figure 3G). Specifically,
a higher BC equilibrium resulted in just a modest increase in
cooperativity but ultimately reached a plateau. Of the three
parameters, tropomyosin stiffness displayed the most potent
modulation of cooperativity.
We next sought to determine whether the effects of
tropomyosin mutations on thin filament activation could be
captured by altering tropomyosin-related model parameters.
To do this, we analyzed a steady-state force-pCa dataset (Bai
et al., 2011) measured in bovine cardiac muscle in which thin
filament proteins were extracted and reconstituted with 100%
human recombinant wild-type or mutant alpha tropomyosin.
Importantly, the tension of the reconstituted filaments in that
study was carefully measured with respect to a reference tension
at 0◦C in the relaxing solution, allowing analysis of not only the
calcium dependent activation but also the calcium independent
activation of the muscle. We began by fitting the wild-type
data using a constrained particle swarm optimization and found
a set of parameters (Table 2, Set 2) that produced a high
fidelity simulation of the reconstituted fibers with wild-type
tropomyosin (Figures 4A,E); the Hill coefficient and pCa50 of
the wild-type simulation curve was almost identical to that of
the experimental curve (Table 2). This parameter set was similar
to the parameter set for skinned cardiac muscle (Set 1) but
included a lower tropomyosin stiffness and non-zero lambda,
which permits loose coupling of troponin and tropomyosin
(Aboelkassem et al., 2015). These differences seem reasonable in
light of the reconstitution process as well as species differences
(rat vs. human/bovine). Previous electron microscopy studies
andmolecular dynamics simulations have established that E180G
and D175N mutations increase the mean deviation angle of the
tropomyosin coiled-coil from a wild-type value of 22.0 degrees
to 27.6 degrees for E180G and 30.5 degrees for D175N (Li
et al., 2012), representing a 25 and 40% decrease in stiffness
respectively. We ran simulations by altering only the stiffness
of the WT fit by these proportions (Figures 4B,F) and found
that these changes alone were insufficient to reproduce the
differences between the mutants and the wild-type data. This
suggests that mutation effects are not confined to stiffness alone
and that other molecular mechanisms should be considered.
Indeed, tropomyosin mutants have previously been determined
to alter the interactions between tropomyosin and the actin
surface (Orzechowski et al., 2014a; Zheng et al., 2016), which
may in turn affect both the blocked-to-closed and closed-to-
open (myosin-induced) transitions of tropomyosin across actin.
We therefore entertained the possibility that introducing changes
to the BC equilibrium constant and duty cycle in addition to
the assumed stiffness changes could produce a reasonable fit
to mutant data. In order to be thorough, a two-dimensional
parameter space for KBC and δ was explored for each mutation
(Figures 4C,D). In both cases, we found a global minimum in
the error landscape, indicating constrained solutions for fitting
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FIGURE 3 | Sensitivity analysis of steady-state force-pCa simulations. (A) Relative steady state force-pCa curves as a function of the tropomyosin stiffness
varied from 50 to 135% of the original fit stiffness of 68e3. (B) Relative steady state force-pCa curves as a function of the BC equilibrium constant varied from 65 to
135% of the original fit BC equilibrium constant of 1.83. (C) Relative steady state force-pCa curves as a function of the duty cycle varied from 65 to 135% of the
original fit duty cycle of 0.47. (D) The maximum steady state force production depended primarily on the myosin duty cycle while BC equilibrium and stiffness have
minor effect. (E) The fraction of the maximum steady state force present at low calcium (pCa 6.0) was strongly shaped by the stiffness with a minor dependence on
the BC equilibrium and duty cycle. (F) Whereas, increased BC equilibrium and duty cycle increase the pCa50, stiffness served to decrease the pCa50. (G)
Cooperativity could be strongly tuned by variation in tropomyosins stiffness and myosin duty cycle whereas BC equilibrium could decrease cooperativity but could not
increase it much above its steady state value.
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A B C D
E F G H
FIGURE 4 | Fitting of wild-type and mutant tropomyosin reconstituted myocardium steady state force production data. (A) Baseline parameters were
found that allowed the model to fit the wild-type data, with D175N tropomyosin mutation data shown for comparison. (B) In order to fit the D175N data, tropomyosin
stiffness was first reduced by 40% and was not sufficient to fit the data. (C) Duty cycle and BC equilibrium were varied systematically while root mean square error of
the model output and the D175N data was calculated, with an error minimum which maintained the baseline duty cycle but decreased the BC equilibrium constant by
15%. (D) The D175N simulation from a prescribed stiffness change and an optimized BC equilibrium decrease show a qualitative fit with the D175N mutant
experiment data. (E) Wild-type data and the model fit shown, with E180G tropomyosin mutation data shown for comparison. (F) In order to fit the E180G data,
tropomyosin stiffness was first reduced by 25% which was not sufficient to fit the data. (G) The error minimum for the E180G heatmap after applying the 25% stiffness
reduction was found to include both a 10% increase in BC equilibrium and a 15% increase in duty cycle. (H) After applying the stiffness change, BC equilibrium
change, and duty cycle change, the E180G simulation shows a qualitative fit with the experimental data for the E180G mutation.
the mutant force-pCa curves. For D175N, the optimal simulation
demanded a decrease in the BC equilibrium by 15%, favoring
the blocked state, in addition to the measured 40% decrease
in tropomyosin stiffness (Figure 4D). For E180G, the optimal
simulation required both an increase in the BC equilibrium
by 10% and an increase in the myosin duty cycle by 15%, in
addition to the reported 25% decrease in tropomyosin stiffness
(Figure 4H). The model therefore suggests that the molecular
consequences of a tropomyosin mutation can include changes in
flexibility, the blocked-to-closed tropomyosin transition, and the
crossbridge-mediated closed-to-open tropomyosin transition but
varies relatively between mutations.
Understanding howmutation-driven changes in skinned fiber
behaviormight relate to the twitch characteristics of intactmuscle
is far from straightforward. The model provides a means of
doing this, by extending the parameter changes determined in
skinned fibers to predict intact muscle contraction. We first
established a baseline set of intact muscle parameters (Table 1,
Set 3) by fitting an isometric rat papillary muscle twitch record
in response to its measured calcium transient (Janssen and de
Tombe, 1997). The newmodel reproduced this dynamic calcium-
activated response just as well as our previous (higher order)
models (Figure 5A). In order to gauge the effects of tropomyosin
stiffness on dynamic muscle activation, we ran twitch simulations
with the same baseline parameter set and calcium transient while
varying γ (Figure 5B). A striking result was the effect of stiffness
on maximum activation of the muscle (Figure 5C). Increasing
tropomyosin stiffness stunted force production potently above
γ values of ∼70 kJ/mol. At the same time, lowering stiffness
resulted in higher fraction of the maximum force being present
at diastolic calcium levels (Figure 5C). The kinetics of muscle
activation as measured by time to peak force (TTP) and
time from peak force to 50% relaxation of muscle (RT50)
were also impacted (Figure 5C). Lowering stiffness tended to
shorten TTP and increase RT50. Altogether, a more flexible
tropomyosin resulted in increased maximum systolic force,
modestly increased diastolic force, shortened TTP, and prolonged
RT50.
Using model parameters (Table 1, Set 3) fitted to mutant
tropomyosin fiber data (Figure 4), we predicted D175N and
E180G effects on twitch force dynamics. For the mutant D175N,
we applied a 40% decrease in stiffness and a 15% decrease in
BC equilibrium constant (Table 1, Set 4) and found that the
twitch was stronger overall with a small increase in diastolic force
fraction (Figures 6A,E,F). Twitch kinetics were also altered, with
a shorter TTP and longer RT50 (Figures 6C,D). For E180G, we
applied a 25% increase in tropomyosin flexibility, 10% increase
in BC equilibrium constant, and 15% increase in duty cycle
(Table 1, Set 5). This yielded a twitch that had a much higher
maximum force production and diastolic fraction. It also had
a much shorter TTP and a much longer RT50 (Figures 6B–F).
While the two twitches produced different properties, they both
embodied faster activation, slower relaxation, and increased
systolic and diastolic force compared to the wild-type.
DISCUSSION
We have considered the potential impacts of tropomyosin
mutations on cardiac muscle function using a new structurally
motivated thin filament model. Accounting for experimentally
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FIGURE 5 | Fitting of intact rat trabeculae twitch with its measured
calcium transient and analysis of its sensitivity to stiffness. (A) Baseline
parameters maintaining the stiffness of skinned rat trabeculae were found that
allowed a model simulation matching the experiment twitch while taking its real
calcium transient as an input. (B) The baseline twitch was perturbed by
variation of the tropomyosin stiffness. (C) Stiffness had complex effects on the
force production and kinetics of twitch, with lower stiffness increasing
maximum and diastolic force production while decreasing time to peak but
increasing time from peak tension to 50% relaxation.
determined azimuthal shifts in tropomyosin (Poole et al., 2006)
allowed us to reduce the dimensionality of our previous model
(Aboelkassem et al., 2015) from 12 free parameters to just eight.
In effect, four parameters that were considered independent are
constrained by structural data and thermodynamic principles in
the new formulation. Along with the reduced dimensionality,
these constraints have made the model more realistic. It
recapitulates observed features of cardiac muscle activation,
including distinct Hill coefficients for upper and lower halves of
the steady-state force-pCa curve (Figure 2B; Dobesh et al., 2002),
strong dependence of the rate of force redevelopment on calcium
(Figure 2A; Brenner, 1988; Fitzsimons et al., 2001) and realistic
calcium-activated twitch transients (Figure 5A). As the model’s
parameters also directly relate to the molecular properties of
tropomyosin, it provided a means for systematic investigation of
HCM-linked tropomyosin mutations. Simulation-based analysis
of skinned fiber data suggests that functional consequences
of TPM1 mutations may be explained by three fundamental
properties, namely tropomyosin chain stiffness, BC equilibrium,
and tropomyosin-mediated changes in the crossbridge duty
cycle.
Our results suggest that each tropomyosin mutation causes
a unique combination of changes to these three molecular
properties, and that specific changes can be estimated by
model analysis when the right data are available. At first
examination, the ability of skinned fiber exchange experiments to
discriminate between tropomyosin molecular property changes
seemed limited. For instance, the pCa value for half-activation
of force (pCa50) is predicted to be highly sensitive to all
three properties (Figure 3F). However, if the mutation effect
on tropomyosin stiffness is known a priori, the model is able
to predict its concomitant impact on pCa50, Hill coefficient,
and maximum/minimum forces (Figures 4B,F). The remaining
discrepancies with mutant data can then be reasonably ascribed
to changes in actin-tropomyosin surface interactions, appearing
as changes to the BC and CM equilibria. Although these
two properties have similar effects on the steady-state force-
pCa curve, only the CM equilibrium (i.e., crossbridge duty
cycle) is predicted to significantly impact maximum calcium-
activated tension. As a consequence, a simple two-parameter
search was able to minimize error between the model and
the mutant fiber data and yield unique parameter values for
KBC and δ (Figures 4C,G). Our approach was facilitated by
recognizing that kinetic rate pairs in the model reduce to
equilibrium coefficients when fitting steady-state measurements.
The subsequent assumption that tropomyosin mutations do not
directly affect the Ca2+ affinity of troponin C left only KBC and δ
as free parameters.
It is worth noting that the precision with which Bai et al.
(2011) performed their skinned fiber studies with wild-type and
mutant tropomyosins was critical to our approach. The calcium-
free force produced in skinned preparations is often not reported
due to technical challenges. Instead, force values at very low
calcium concentrations are frequently assumed to be equivalent
to zero. However, as our analysis demonstrates, force-pCa curves
that are made to start at zero do not allow clear differentiation
between competing biophysical changes such as tropomyosin
stiffness and the apparent crossbridge duty cycle. Hence, while
D175N and E180G mutations have been studied by others in
various experimental systems (Bottinelli et al., 1998; Michele
et al., 1999; Muthuchamy et al., 1999; Evans et al., 2000; Wang
et al., 2011; Rysev et al., 2012), we selected the data of Bai et al.
for the analysis here because it is the only applicable data set
of which we are aware that reports absolute force measurements
under very low calcium conditions.
Although tropomyosin stiffness can be directly studied via
electron microscopy as well as atomic force microscopy (Li et al.,
2010, 2012; Loong et al., 2012b) and simulated using molecular
dynamics, no comparable approaches yet exist for obtaining
estimates of the intrinsic BC and CM state equilibria. Hence,
direct validation of our predictions for the E180G and D175N
mutation effects onKBC and δ are not possible at present. Instead,
we must rely on indirect evidence to corroborate our estimates.
For instance, in previous work, the electrostatic interactions
was computed between tropomyosin and actin residues as
tropomyosin is moved axially and azimuthally over the actin
surface (Orzechowski et al., 2014a). This allows construction of
energy landscapes for wild-type and mutant tropomyosins. In
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FIGURE 6 | Prediction of mutant twitch based on properties altered by mutant tropomyosin from fitting of the reconstituted myocardium data. (A)
D175N mutant twitch was predicted by applying a 40% increase in stiffness and a 15% decrease in BC equilibrium constant. (B) E180G mutant twitch was predicted
by applying a 15% increase in duty cycle, 10% increase in BC equilibrium, and 25% reduction in stiffness. (C) Both E180G and D175N mutants reduced the time to
peak to the minimum value possible in the model for the given measured calcium transient. (D) E180G and D175N increased the time from peak tension to 50%
relaxation though D175N was predicted to be far more modest than E180G. (E,F) Both E180G and D175N mutants were predicted to increase maximum and
diastolic force production though E180G had a larger effect.
the absence of a reliable way to calculate entropic changes in this
milieu, a direct estimate of the free energy changes between B and
C states cannot be accurately made. However, qualitative insight
is possible. We predicted from fitting fiber data that the E180G
mutation would cause a 10% increase inKBC, indicating a relative
increase in the free energy associated with the B state. This agrees
well with the prediction of Orzechowski et al. (2014a) that the
E180G substitution would cause a ∼40 kJ/mol increase in the
electrostatic potential of the B state. Corresponding analysis of
the actin surface interactions of D175N tropomyosin showed the
changes in that case were quite small. Although we found a global
fit for D175N suggesting a 15% decrease in KBC (Figure 4C), the
slope of the error surface is sufficiently shallow that reasonable fits
can also be obtained by assuming no change in KBC and a slight
decrease in δ. In light of the predicted absence of actin surface
interaction changes and the shallowness of the error landscape
(Figure 4C), we conclude that the majority of D175N effects are
explained by reduced tropomyosin chain stiffness (Figure 4B).
Placing less importance on equilibrium effects also seems prudent
in light of at least one study (Evans et al., 2000) that reports
increased myofilament Ca2+ sensitivity in mouse myocardium
expressing D175N tropomyosin, as opposed to the unchanged
pCa50 seen in the data of Bai et al. (2011). Increased Ca
2+
sensitivity is consistent with the model-predicted effects of a pure
decrease in tropomyosin stiffness (Figure 4B).
Another way of indirectly validating our predictions is to
look at how E180G affects intact muscle twitches. Our model
generally predicts outcomes that are consistent with those data.
When predicting the effect of HCM-related mutations E180G
and D175N on intact muscle, we found that E180G is more
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severe than D175N (starting from a rat twitch background
and calcium transient). This aligns with observations that
transgenic mice expressing E180G show a severe phenotype
and often die within 6 months of age, while those expressing
D175N display a milder phenotype (Redwood and Robinson,
2013). At the same time, both mutations were predicted in
the model to cause increased diastolic and systolic tension.
Similar behavior has been consistently demonstrated in studies
of myocardium containing mutant tropomyosin. Isometric force
measurements of permeabilized myocytes with both adenovirally
expressed D175N and E180G showed high force production
at low calcium (Michele et al., 1999). In terms of twitch
kinetics, only E180G has been extensively characterized, but
these results largely agree with our predictions. Papillary
muscles isolated from transgenic E180G mice showed a slightly
longer time to peak and a severe slowing of relaxation by
almost 60% compared to control (Sheehan et al., 2011).
Adult cardiomyocytes isolated from these animals showed
increased magnitude of unloaded shortening of approximately
300% (Sheehan et al., 2011), which also agrees with our
predictions.
One puzzling component to understanding pathogenicity
of D175N tropomyosin is that is displays a reduced calcium
sensitivity compared to wild-type, and no increase in maximally
activated steady-state force (Bai et al., 2011). This seemingly
contradicts the notion that HCM mutations are generally
hypercontractile in nature. However, we find it interesting
that our simulated D175N twitch is in fact hypercontractile
(Figure 6A), with a predicted 28% increase in peak twitch
force. According to the model, cooperativity-linked kinetic
effects explain how D175N can increase twitch tension even
while having a reduced steady-state calcium sensitivity. The
large drop in tropomyosin stiffness associated with D175N
means that nearest-neighbor RUs are less strongly coupled.
At sub-maximal calcium levels (such as those occurring in
a transiently-activated twitch event), weaker RU-RU coupling
actually allows tension to develop more rapidly. Hence, although
D175N ultimately limits the steady-state force, it develops force
more quickly and thus reaches a higher level than wild-type
during a short twitch event. This modeling result illustrates
the limitations of using steady-state force-pCa curves and
their properties as the sole means of understanding mutation
pathogenicity.
In addition to the primary sarcomeric effects, HCM is
characterized by myocardial remodeling, specifically concentric
hypertrophy, fibrosis, and myocardial disarray (Teerkaririkul
et al., 2012). Excess diastolic tension (Bai et al., 2013) as
well as hypercontractility, may represent a common pathway
for how tropomyosin mutations act to initiate HCM-type
ventricular remodeling. Recent work suggests that increased
myofilament tension during the twitch cycle, calculated as the
scalar tension-time integral, induces ERK1/2 signaling leading
to HCM-like hypertrophic remodeling (Davis et al., 2016).
Our twitch predictions for E180G and D175N both achieve
higher peak tension, and have tension-time integrals that exceed
wild-type. Even though the final mutant twitches appear quite
different from each other, the tension-time integral could explain
why both are capable of driving concentric cardiomyocyte
hypertrophy. Reducing myofilament activation in E180G mice
by either increasing calcium uptake through knocking out
phospholamban (Gaffin et al., 2011) or by co-expression of
pseudophosphorylated TnI (Alves et al., 2014) was previously
shown to decrease ERK1/2 signaling and prevent pathological
hypertrophy. Furthermore, our model suggests than D175N
would appear milder than E180G when it comes to these metrics,
which is consistent with evidence that E180G has much more
severe remodeling and disease than D175N (Redwood and
Robinson, 2013).
While the twitch predictions show fairly extreme changes
in the presence of mutations, particularly for E180G, it
should be noted that these are the simulated effects of
100% replacement of wild-type tropomyosin with mutant
tropomyosin. The clinical scenario is certainly different. In
studies of HCM patients, monoallelic D175N is expressed to
a similar amount as wild-type (Bottinelli et al., 1998) which
would lead to coiled-coils consisting of a presumed mixture
of 25% wild-type homodimers, 25% mutant homodimers, and
50% heterodimers. Recent biochemical studies with E180G
and D175N show that the 1:2:1 ratio of dimers is formed
in solution and that there was only a very slight preference
for wild-type versus mutant tropomyosin when it came to
binding of actin (Janco et al., 2012). However, for other
properties of heterodimers such as calcium sensitivity, there was
not necessarily a consistent trend of heterodimers mimicking
homodimers (Janco et al., 2012). Therefore, our model
utilizing complete replacement of wild-type homodimers with
mutant homodimers would predict the worst case scenario.
Furthermore, our model does not take into account any
cellular adaptation that may occur as a result of a sarcomeric
perturbation, such as tropomyosin phosphorylation, calcium
transient changes through regulation such as phospholamban,
and other myofilament post-translational changes (Teerkaririkul
et al., 2012; Redwood and Robinson, 2013). Presumably, some of
these adaptations may act to alleviate the functional phenotype
and lead to milder dysfunction than predicted.
Although the model provides valuable insights, it is important
to consider some of its limitations. Like our previous models,
we employed an RU-level discretization of the thin filament.
This means that any effects arising from intra-RU phenomena
are absent and that effectively only one myosin crossbridge is
represented per RU (see discussion in Campbell et al., 2010).
Also, at present the model is only capable of simulating isometric
contraction. We did not explicitly represent tropomyosin-
troponin T interactions in the model, even though recent
evidence has emerged suggesting their potential modulation by
tropomyosin mutations (Orzechowski et al., 2015) and possible
effects on tropomyosin chain stiffness (Sousa et al., 2010). Such
interactions are still of unclear significance with regards to thin
filament regulation, but could explain some shortcomings of
the present model. Specifically, the model deviates from the
measured E180G exchange data at low Ca2+ concentrations
(Figure 4H). The only way of reconciling this deviation is to
assume that the drop in overall tropomyosin chain stiffness is
not as large as that measured for individual E180G tropomyosin
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dimers. It is possible that in the presence of troponin T the
effect of E180G on stiffness is reduced. With the appropriate
structural information, tropomyosin-troponin T interactions
could be included in future modeling efforts.
Of possible consequence to the present study, the discretized
thin filament requires us to translate proportional tropomyosin
stiffness into energy via a simple unidimensional deformation. As
such, we do not account for some of the more complex motions
of tropomyosin geometry as considered in continuous flexible
chain type models (Smith and Geeves, 2003; Smith et al., 2003;
Mijailovich et al., 2012; Metalnikova and Tsaturyan, 2013; Land
and Niederer, 2015). One possible consequence of leaving out
this complexity is that the simplified model might not behave in
a realistic matter. Given the model’s ability to produce several
fundamental muscle phenomena, any such limitations seem
likely to be second order in nature. Another possibility is that
the simplified model yields realistic behavior but can only do so
when assuming unrealistic parameter values. To examine this, we
compared our estimate of tropomyosin chain bending stiffness
per unit length (obtained by fitting cardiac muscle force-pCa
data) to the estimate used by Smith et al. (2003) and Smith and
Geeves (2003). They estimated a value of 2.5×10−44 Nm4 for the
bending stiffness per unit length; while using our fitted value for
the apparent chain stiffness (Table 1), we would back calculate
a value of 1.3 × 10−44 Nm4. Considering the simplifications
involved, the agreement of these values to well within an order
of magnitude seems reasonable.
A few additional details surrounding the exchange
experiments of Bai et al. (2011) should be considered. They
used recombinant human tropomyosin with an added Gly-
Ser sequence at the N-terminus to approximate acetylation
(Monteiro et al., 1994). N-terminal acetylation of tropomyosin
stabilizes its coiled-coil structure and hence could be an
important determinant of overall tropomyosin chain stiffness
(Greenfield et al., 1994). Although the work of Monteiro et al.
(1994) that the dipeptide extension is functionally equivalent
to acetylation, there may still be differences between native and
recombinant tropomyosins. This may explain why values for
the effective tropomyosin chain stiffness (γ ) fit to skinned rat
cardiac tissue data differ from those fit to bovine myocardium
reconstituted with recombinant human tropomyosin. Another
factor to contemplate is that the various experimental data sets
were acquired at different temperatures. In order to ascribe the
effects of tropomyosin mutations on γ and other parameters as
uncovered by fitting to the data of Bai et al. (2011) we computed
their proportional effect and then applied the same proportional
changes to the baseline parameters fitted to intact rat cardiac
twitch data.
Although significant progress has been made already toward
modeling the thin filament and tropomyosin at different scales,
we present here the first attempt of which we are aware to model
tropomyosin mutations in an integrative manner and predict
their effects on intact muscle function. In the future, the spatially
discretized thin filament approach will also allow simulations
with stochastic assembly of wild-type and mutant homodimers
and heterodimers which may have important implications for
pathogenesis (Janco et al., 2012). We are also continuing
work toward a discretized coarse-grain model of tropomyosin
and incorporation of sarcomere length dependence, which
will improve the ability of the model to translate biophysical
alterations of tropomyosin into functional simulations.
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